Search

Your search keyword '"Glycerol -- Dosage and administration"' showing total 13 results
Start Over Descriptor "Glycerol -- Dosage and administration"
13 results on '"Glycerol -- Dosage and administration"'

1. Recent Research from State University Maringa Highlight Findings in Hypoglycemia (Glycerol Potentiates the Effects of Glucose In Promoting Glucose Recovery During Hypoglycemia: From Basic To Clinical Investigations and Their Therapeutic ...)

Subjects
Glycerin -- Dosage and administration, Glucose monitors -- Usage -- Health aspects, Dextrose -- Dosage and administration, Glycerol -- Dosage and administration, Glucose -- Dosage and administration, Hypoglycemia -- Diagnosis -- Care and treatment, Health
Abstract

2022 OCT 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Nutritional and Metabolic Diseases and Conditions - Hypoglycemia are [...]

Published
2022

2. New Corpus Luteum Hormones Data Have Been Reported by Researchers at Bihar Veterinary College (Effect of Lowering Blood Cortisol Level Along With Progesterone Priming On Intensifying the Secondary Symptoms of Oestrus In Murrah Buffaloes During ...)

Subjects
Glycerin -- Dosage and administration, Glycerol -- Dosage and administration, Progesterone -- Analysis, Hydrocortisone -- Measurement -- Health aspects, Injections, Intramuscular -- Usage -- Health aspects, Luteinizing hormone -- Analysis, Health
Abstract

2022 OCT 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Hormones - Corpus Luteum Hormones. According to [...]

Published
2022

3. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial

Author

Peltola, Heikki, Roine, Irmeli, Fernandez, Josefina, Zavala, Ines, Ayala, Silvia Gonzalez, Mata, Antonio Gonzalez, Arbo, Antonio, Bologna, Rosa, Mino, Greta, Goyo, Jose, Lopez, Eduardo, de Andrade, Solange Dourado, and Sarna, Seppo

Subjects
Bacterial meningitis -- Demographic aspects, Bacterial meningitis -- Drug therapy, Glycerin -- Dosage and administration, Glycerin -- Physiological aspects, Glycerol -- Dosage and administration, Glycerol -- Physiological aspects, Dexamethasone -- Dosage and administration, Dexamethasone -- Physiological aspects, Placebos -- Usage, Hemophilus influenzae -- Health aspects, Experimental design, Health, Health care industry
Published
2007

4. Cost-effectiveness analysis of the terlipressin-glycerin trinitrate combination in the pre-hospital management of acute gastro-intestinal haemorrhage in cirrhotic patients

Author

Combier, E., Levacher, S., Letoumelin, P., Joseph, A., Pourriat, J.-L., and de Pouvourville, G.

Subjects
Gastrointestinal bleeding -- Drug therapy, Drug therapy, Combination -- Finance, Vasoconstrictors -- Dosage and administration, Glycerin -- Dosage and administration, Glycerol -- Dosage and administration, Liver cirrhosis -- Complications and side effects, Company financing, Health care industry
Abstract

Byline: E. Combier (1), S. Levacher (2), P. Letoumelin (3), A. Joseph (4), J.-L. Pourriat (2), G. de Pouvourville (1) Abstract: Objectives: To assess the cost-effectiveness of an early treatment of upper gastro-intestinal haemorrages in cirrhotic patients. Design: Utilization data linked to the results of a double-blind, placebo-controlled trial demonstrating the efficacy of the terlipressin-glycerin trinitrate combination (TER-GTN) in the reduction of mortality at day 42 for haemorragic patients due to rupture of oesophageal varices. Setting: Hopital Jean Verdier, Bondy, Assistance Publique-Hopitaux de Paris, France. Subjects: Eighty-four patients included over 2 years by emergency services and hospitalized in an intensive care unit (ICU) for haemorrage, 41 in the 'treated' group and 43 in the 'placebo' group. Main outcome measures: Mortality at day 42, cost per death avoided. Results: The mortality rate in the placebo group was 46.5 % versus 27.5 % in the treated group. The mean length of stay was 5 days longer in the treatment group. The excess cost per death avoided was 25,849 FF. Of this extra cost 27 % was due to treatment and 24 % was due to increased length of stay. The excess cost per case treated was FF 5,097, 10 % of the total cost per stay for rupture of oesophageal varices (ROV). Conclusions: Our results are of the same magnitude as those published by Mac Cormick et al. in the United Kingdom for similar treatment. The extra cost appears to be moderate, and much lower than monoclonal antibody therapy for sepsis. The impact on the study hospital budget did not exceed 1.7 10.sup.--4. Author Affiliation: (1) Ecole Nationale de la Sante Publique, Groupe IMAGE-ENSP, 14 rue du Val d'Osne, F-94 410 Saint-Maurice, France e-mail: gdepouvo@ensp.fr Tel. + 3 31 (43) 96 64 18 Fax + 331(43)96 65 29, FR (2) Department of Anaesthesia and Intensive Care, CHU Jean Verdier, F-93140 Bondy, France, FR (3) Service d'Aide Medicale Urgente, SAMU 93, F-93000 Bobigny, France, FR (4) Annie Chicoye Economics, 33 rue Fortuny F-75017 Paris, France, FR Article note: Received: 23 June 1998 Accepted: 18 January 1999

Published
1999

5. Caught between a rock and a hard place: a 3-year-old with buttock pain

Author

Hanson, David and Siberry, George K.

Subjects
Constipation -- Case studies, Constipation -- Development and progression, Constipation -- Care and treatment, Glycerin -- Dosage and administration, Glycerol -- Dosage and administration, African American children -- Medical examination, Abdominal pain in children -- Causes of, Abdominal pain in children -- Case studies, Bladder -- Calculi, Bladder -- Causes of, Bladder -- Care and treatment, Bladder -- Case studies
Published
2007

7. Glycerol and bacterial meningitis

Author

Saez-Llorens, Xavier and McCracken, George H. Jr.

Subjects
Hemophilus meningitis -- Causes of, Hemophilus meningitis -- Development and progression, Hemophilus meningitis -- Care and treatment, Glycerin -- Dosage and administration, Glycerin -- Physiological aspects, Glycerol -- Dosage and administration, Glycerol -- Physiological aspects, Hemophilus influenzae -- Health aspects, Health, Health care industry
Published
2007

9. Administering a glyceryl trinitrate infusion: big is not always best

Author

Reed, Matthew J.

Subjects
Glycerin -- Dosage and administration, Glycerin -- Research, Glycerol -- Dosage and administration, Glycerol -- Research, Heart failure -- Care and treatment, Intravenous catheterization -- Standards, Intravenous catheterization -- Research, Emergency medical services -- Research, Health
Published
2007

10. Glycerol effective for children's bacterial meningitis

Author

Zoler, Mitchel L.

Subjects
Mortality -- Risk factors, Mortality -- Prevention, Mortality -- United States, Children -- Health aspects, Glycerin -- Dosage and administration, Glycerol -- Dosage and administration, Bacterial meningitis -- Drug therapy
Abstract

WASHINGTON -- Adjunctive treatment with oral glycerol was more effective than intravenous dexamethasone for preventing death and severe neurologic sequelae in children with bacterial meningitis in a controlled study with [...]

Published
2005

11. Glycerol aids outcomes in bacterial meningitis

Author

Zoler, Mitchel L.

Subjects
Bacterial meningitis -- Drug therapy, Glycerin -- Dosage and administration, Glycerin -- Testing, Glycerol -- Dosage and administration, Glycerol -- Testing, Children -- Diseases, Children -- Drug therapy, Health, Health care industry
Abstract

WASHINGTON -- Adjunctive treatment with oral glycerol was more effective than intravenous dexamethasone for preventing death and severe neurologic sequelae in children with bacterial meningitis in a controlled study with [...]

Published
2005

12. Glycerin (rectal)

Subjects
Colace (Medication) -- Complications and side effects, Colace (Medication) -- Dosage and administration, Colace Infant/Child (Medication) -- Dosage and administration, Colace Infant/Child (Medication) -- Complications and side effects, Fleet Glycerin Maximum Strength (Medication) -- Dosage and administration, Fleet Glycerin Maximum Strength (Medication) -- Complications and side effects, Fleet Glycerin Suppositories (Medication) -- Dosage and administration, Fleet Glycerin Suppositories (Medication) -- Complications and side effects, Sani-Supp (Medication) -- Complications and side effects, Sani-Supp (Medication) -- Dosage and administration, Glycerin -- Dosage and administration, Glycerin -- Complications and side effects, Glycerol -- Dosage and administration, Glycerol -- Complications and side effects, Constipation -- Drug therapy
Published
2008

13. Investigational Neuroprotective Drugs in Traumatic Brain Injury

Author

Cawley, Michael J., Marburger, Robert K., and Earl, Grace L.

Subjects
Osmotic pressure -- Drug therapy, Brain -- Injuries, Cerebral edema -- Drug therapy, Diuretics -- Product development, Mannitol -- Dosage and administration, Glycerol -- Dosage and administration, Barbiturates -- Usage, Pharmaceutical industry -- Product development, Neuropsychopharmacology -- Research
Abstract

In traumatic brain injury research the process of neuronal cell death and the role neuroprotective agents can play are being investigated. Neuroprotective agents should be given soon after injury to inhibit waves of mediators that bring on secondary injury. No FDA-approved drugs now exist for the indication. A number of investigational agents are being evaluated in clinical trials. Phase II and III drug studies are being conducted in brain-injured patients to evaluate the safety and effectiveness for cutting down mortality and improving functional outcome., Introduction Current researchers are discovering the intricate process of neuronal cell death and establishing the role of neuroprotective agents in improving outcomes following acute traumatic brain injury. Neuroprotective agents are [...]

Published
1998

Catalog

Books, media, physical & digital resources
See catalog results